← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2001Last known activity
Sep 30, 2025
Timeline
1780s
- Jun 1, 1785
University of Georgia— Founded
Drugs by trial phase (32 distinct, 30 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07120997CollaboratorN/ASep 30, 2025
- NCT06382298OfficialN/AAug 31, 2024
- NCT06382298Sponsor investigatorN/AAug 31, 2024
- NCT06382298Lead sponsorN/AAug 31, 2024
- NCT06424756Lead sponsorPhase 2Jul 1, 2024
- NCT06424756Sponsor investigatorPhase 2Jul 1, 2024
- NCT06742398Sponsor investigatorN/AFeb 16, 2024
- NCT06742398Lead sponsorN/AFeb 16, 2024
- NCT06742398OfficialN/AFeb 16, 2024
- NCT06383117OfficialN/AOct 17, 2023
- NCT06383117Lead sponsorN/AOct 17, 2023
- NCT06383117Sponsor investigatorN/AOct 17, 2023
- NCT05949879Overall official - principal investigatorN/AAug 1, 2023
- NCT05949879Lead sponsorN/AAug 1, 2023
- NCT05949879Reponsible party - principal investigatorN/AAug 1, 2023
Details
- Founded
- Athens, GA, US Jun 1, 1785
- Last known activity
- Sep 30, 2025